VALDEMBRI, Donatella

VALDEMBRI, Donatella  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 51 (tempo di esecuzione: 0.08 secondi).
Titolo Data di pubblicazione Autore(i) File
3D simulations of early blood vessel formation 2007 CAVALLI F; GAMBA A; NALDI G; M. SEMPLICE; VALDEMBRI D; SERINI G
Aminopeptidase A is a functional target in angiogenic blood vessels 2004 MARCHIÒ S; LAHDENRANTA J; SCHLINGEMANN RO; VALDEMBRI D; WESSELING P; ARAP MA; HAJITOU A; OZAWA MG; TREPEL M; GIORDANO RJ; NANUS DM; DIJKMAN HB; OOSTERWIJK E; SIDMAN RL; COOPER MD; BUSSOLINO F; PASQUALINI R; ARAP W
Angiogenesis: a balancing act between integrin activation and inhibition? 2009 Bussolino F; Caccavari F; Valdembri D; Serini G
Angiogenesis: The Importance of RHOJ-Mediated Trafficking of Active Integrins 2020 Valdembri D.; Serini G.
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 2008 ORSO F; PENNA E; CIMINO D; ASTANINA E; MAIONE F; VALDEMBRI D; GIRAUDO E; SERINI G; SISMONDI P; DE BORTOLI M; TAVERNA D
Axonal precursor miRNAs hitchhike on endosomes and locally regulate the development of neural circuits 2020 Corradi, Eloina; Dalla Costa, Irene; Gavoci, Antoneta; Iyer, Archana; Roccuzzo, Michela; Otto, Tegan A; Oliani, Eleonora; Bridi, Simone; Strohbuecker, Stephanie; Santos-Rodriguez, Gabriela; Valdembri, Donatella; Serini, Guido; Abreu-Goodger, Cei; Baudet, Marie-Laure
CCL16 activates an angiogenic program in vascular endothelial cells 2004 Strasly M; Doronzo G; Cappello P; Valdembri D; Arese M; Mitola S; Moore P; Alessandri G; Giovarelli M; Bussolino F.
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. 2003 SERINI G; VALDEMBRI D; ZANIVAN S; MORTERRA G; BURKHARDT C; CACCAVARI F; ZAMMATARO L; PRIMO L; L. TAMAGNONE; LOGAN M; TESSIER-LAVIGNE M; TANIGUCHI M; PUSCHEL AW; BUSSOLINO F
Class 3 semaphorins in cardiovascular development 2016 Valdembri, Donatella; Regano, Donatella; Maione, Federica; Giraudo, Enrico; Serini, Guido
Conformationally active integrin endocytosis and traffic: why, where, when and how? 2020 Mana, Giulia; Valdembri, Donatella; Serini, Guido
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 2021 Coppo R.; Orso F.; Virga F.; Dalmasso A.; Baruffaldi D.; Nie L.; Clapero F.; Dettori D.; Quirico L.; Grassi E.; Defilippi P.; Provero P.; Valdembri D.; Serini G.; Sadeghi M.M.; Mazzone M.; Taverna D.
Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease 2006 COLUCCI S; TARABOLETTI G; PRIMO L; VIALE A; ROCA C; VALDEMBRI D; GEUNA M; PAGANO M; GRANO M; POGREL AM; HARRIS AL; ATHANASOU NN; MANTOVANI A; ZALLONE A; BUSSOLINO F
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. 2002 SGADARI C; BACILLARI G; TOSCHI E; CARLEDI D; BACICALUPPO I; BACCARINI S; PALLADINO C; LEONE S; VALDEMBRI D; F. BUSSOLINO; MONINI P; ENSOLI B
HIV protease inhibitors block angiogenesis and promote regression of Kaposi's sarcoma in the nude mouse model 2002 Sgadari C; Carlei D; Barillari G; Toschi E; Bacigalupo I; Palladino C; Malavasi L; Baccarini S; Bugarini R; Marinelli R; Falchi M; D. Valdembri ; F. Bussolino ; Monini P; Ensoli
Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. 2003 ROCA C; PRIMO L; VALDEMBRI D; CIVIDALLI A; DECLERK P; CARMELIET P; GABRIELE P; F. BUSSOLINO
In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF 2002 VALDEMBRI D; G. SERINI; VACCA A; RIBATTI D; BUSSOLINO F
Increasing traffic on vascular routes 2011 M. Santambrogio; D. Valdembri; G. Serini
Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor 2005 GALLICCHIO M; MITOLA S; VALDEMBRI D; FANTOZZI R; VARNUM B; AVANZI GC; BUSSOLINO F
Integrin signaling and lung cancer 2010 Caccavari F; Valdembri D; Sandri C; Bussolino F; Serini G
Integrins and angiogenesis: a sticky business 2006 Serini, G; Valdembri, D; Bussolino, F.